Japan Medical Dynamic Marketing, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3689100000
JPY
541.00
13 (2.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
6,318.34
5,690.39
5,920.10
6,655.19
6,640.88
5,765.09
6,052.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,318.34
5,690.39
5,920.10
6,655.19
6,640.88
5,765.09
6,052.88
Raw Material Cost
2,925.74
2,654.16
2,616.88
3,044.41
2,832.88
2,454.86
2,573.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
53.40
48.71
43.00
29.86
21.35
14.63
12.01
Selling and Distribution Expenses
2,887.28
2,725.93
2,934.73
3,007.01
2,950.27
2,736.11
2,836.20
Other Expenses
14.20
20.39
17.51
20.40
23.59
21.78
22.44
Total Expenditure (Excl Depreciation)
6,008.41
5,632.71
5,769.65
6,285.30
6,040.44
5,423.36
5,646.53
Operating Profit (PBDIT) excl Other Income
309.9
57.699999999999996
150.39999999999998
369.90000000000003
600.4
341.70000000000005
406.4
Other Income
79.75
9.89
-10.33
-21.73
-19.66
-3.53
2.77
Operating Profit (PBDIT)
793.11
462.32
538.19
716.92
964.19
711.74
792.39
Interest
53.40
48.71
43.00
29.86
21.35
14.63
12.01
Exceptional Items
-0.10
-7.72
0.00
-1,778.41
0.00
0.00
0.07
Gross Profit (PBDT)
3,392.59
3,036.23
3,303.22
3,610.78
3,808.00
3,310.23
3,478.97
Depreciation
403.44
394.74
398.08
412.22
423.56
412.32
423.34
Profit Before Tax
336.17
11.14
97.12
-1,503.57
519.28
284.79
357.11
Tax
112.33
4.68
28.43
-136.08
122.86
63.82
76.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
217.43
3.92
65.88
-1,340.99
382.67
222.98
273.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
217.43
3.92
65.88
-1,340.99
382.67
222.98
273.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.41
2.54
2.81
-26.50
13.74
-2.02
7.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
223.84
6.46
68.68
-1,367.49
396.41
220.96
281.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
25,123.39
24,320.03
23,955.06
24,679.26
26,700.76
24,819.81
26,323.94
Earnings per share (EPS)
8.25
0.15
2.5
-50.92
14.53
8.47
10.39
Diluted Earnings per share
8.25
0.15
2.5
-50.92
14.53
8.47
10.39
Operating Profit Margin (Excl OI)
4.91%
1.01%
2.54%
4.9%
8.44%
5.25%
6.05%
Gross Profit Margin
11.71%
7.13%
8.36%
-16.4%
14.2%
12.09%
12.89%
PAT Margin
3.44%
0.07%
1.11%
-20.15%
5.76%
3.87%
4.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 11.03% vs -3.88% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 3,343.08% vs -90.54% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 57.69% vs -17.52% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 9.65% vs 13.26% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Japan Medical Dynamic Marketing, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
6,318.34
635.72
5,682.62
893.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,318.34
635.72
5,682.62
893.89%
Raw Material Cost
2,925.74
309.60
2,616.14
845.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
53.40
0.00
53.40
Selling and Distribution Expenses
2,887.28
298.42
2,588.86
867.52%
Other Expenses
14.20
15.73
-1.53
-9.73%
Total Expenditure (Excl Depreciation)
6,008.41
765.34
5,243.07
685.06%
Operating Profit (PBDIT) excl Other Income
309.92
-129.61
439.53
339.12%
Other Income
79.75
157.90
-78.15
-49.49%
Operating Profit (PBDIT)
793.11
46.94
746.17
1,589.63%
Interest
53.40
0.00
53.40
Exceptional Items
-0.10
0.00
-0.10
Gross Profit (PBDT)
3,392.59
326.13
3,066.46
940.26%
Depreciation
403.44
18.66
384.78
2,062.06%
Profit Before Tax
336.17
28.29
307.88
1,088.30%
Tax
112.33
0.85
111.48
13,115.29%
Provisions and contingencies
0
0
0.00
Profit After Tax
217.43
27.44
189.99
692.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
217.43
27.44
189.99
692.38%
Share in Profit of Associates
0
0
0.00
Minority Interest
6.41
0.00
6.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
223.84
27.44
196.40
715.74%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
25,123.39
8,788.97
16,334.42
185.85%
Earnings per share (EPS)
8.25
0.29
7.96
2,744.83%
Diluted Earnings per share
8.25
0.29
7.96
2,744.83%
Operating Profit Margin (Excl OI)
4.91%
-20.39%
0.00
25.30%
Gross Profit Margin
11.71%
7.38%
0.00
4.33%
PAT Margin
3.44%
4.32%
0.00
-0.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 631.83 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 11.03% vs -3.88% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -4.86% vs 9.92% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 22.38 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3,343.08% vs -90.54% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -43.54% vs -1.02% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 71.34 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 57.69% vs -17.52% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -27.49% vs 1.87% in Dec 2024

Quarterly - Interest
Interest 5.34 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.65% vs 13.26% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 150.70% vs 95.41% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.91%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024